Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,780 | 80,506 | 147,440 | 188,207 | 126,381 |
| Marketable Securities | 183,198 | 215,214 | 196,458 | 197,814 | 176,692 |
| Receivables | 6,204 | 6,204 | 204 | 5,679 | 3,981 |
| Other current assets | 2,000 | 0 | 5,000 | 0 | 0 |
| TOTAL | $280,484 | $311,118 | $358,445 | $396,281 | $310,768 |
| Non-Current Assets | |||||
| PPE Net | 13,522 | 11,340 | 9,569 | 8,345 | 6,960 |
| Investments And Advances | 123,685 | 137,189 | 121,480 | 110,440 | 77,191 |
| Other Non-Current Assets | 20,029 | 17,124 | 3,580 | 2,915 | 1,741 |
| TOTAL | $157,236 | $165,653 | $134,629 | $121,700 | $85,892 |
| Total Assets | $437,720 | $476,771 | $493,074 | $517,981 | $396,660 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,014 | 6,650 | 3,861 | 5,405 | 4,388 |
| Accrued Expenses | 11,419 | 14,549 | 11,569 | 7,678 | 10,833 |
| TOTAL | $66,049 | $66,258 | $50,680 | $46,844 | $47,972 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 43,186 | 41,212 | 35,250 | 33,761 | 32,751 |
| Other Non-Current Liabilities | 10,326 | 9,189 | 796 | 837 | 832 |
| TOTAL | $65,754 | $68,211 | $67,177 | $72,959 | $78,555 |
| Total Liabilities | $131,803 | $134,469 | $117,857 | $119,803 | $126,527 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,950 | 44,738 | 44,613 | 44,427 | 44,347 |
| Common Shares | 45 | 45 | 45 | 44 | 39 |
| Retained earnings | -263,425 | -220,892 | -183,190 | -154,355 | -127,973 |
| Other shareholders' equity | -2,066 | -608 | -59 | 30 | 49 |
| TOTAL | $305,917 | $342,302 | $375,217 | $398,178 | $270,133 |
| Total Liabilities And Equity | $437,720 | $476,771 | $493,074 | $517,981 | $396,660 |